The Latest Cardiac and Vascular News
MORRISVILLE, N.C., June 24, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for 2,000 shares of Liquidia’s common stock to a newly hired non-executive employee under the Liquidia Corporation 2022 Inducement Plan (the “Inducement Plan”). The stock option was granted […]
Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced pricing of its previously-announced best efforts underwritten public offering of up to […]
MINNEAPOLIS, June 22, 2022 /PRNewswire/ — The job of the CEO is to create great value for stakeholders. More than any position, the CEO’s impact is the single biggest predictor of company success. What the CEO controls accounts for up to 45% of company performance. “Exceptional CEOs create great value. But, for […]
PRAIRIE VILLAGE, Kan., June 23, 2022 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the appointment of veteran medical device executive Joseph Ingoglia as Chief Commercial Officer. Ingoglia will be responsible for building Artio’s sales and marketing teams and driving revenue […]
Seasoned healthcare executive added as Bodyport commercial efforts ramp up SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I am excited to join the Bodyport Board of Directors as […]
Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Commercial Execution in High Growth Companies SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure (HF), today announced that Mark Miles has joined the company as Chief Commercial Officer (CCO). He […]
BOSTON, June 22, 2022 /PRNewswire/ — Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round. The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex Ventures, IAG […]
SILVER SPRING, Md., June 21, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced Aziyo co-founder C. Randal (Randy) Mills, Ph.D., has been appointed interim president and […]
Krummen to spearhead commercialization and product evolution of innovative arrhythmia mapping technology SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first rapid technology to non-invasively map arrhythmias in all four chambers of the heart, today announced the appointment of Rob Krummen as CEO. After five years serving as CEO, Mike Monko […]
Respected leaders bring deep industry expertise and diverse perspectives to further enable company’s substantial growth CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the appointment of Henrietta Fore and Stacy Enxing Seng to the company’s Board of Directors, effective immediately. “The addition of Henrietta and Stacy to Imperative Care’s Board of Directors […]
